Mitsubishi UFJ Trust & Banking’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$333K	Buy	+5,213	New	+$270K	﹤0.01%	1188

Other funds holding KNSA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's KNSA Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 5,213 shares worth $333K. The stake represents ﹤0.01% of the portfolio and ranks #1188 among its holdings.

94 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 5,213 shares of Kiniksa Pharmaceuticals worth $333K as of Q2 2026.
Kiniksa Pharmaceuticals was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Kiniksa Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1188 holding.
94 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.